The FDA has approved a new option for the treatment of HIV-1 in adults as a replacement for current antiretroviral regimens in patients who are virologically suppressed and with no history of treatment...
In a recent study, researchers examined the global burden and associated disparities of hepatitis B virus infection in patients with human immunodeficiency virus.
The investigators used multiple quantitative metabolomic assays to discover a prognostic profile best able to predict ascites, hepatic encephalopathy, hepatocellular carcinoma, and other end-stage liver...
In a new study presented at AASLD 2020, researchers aimed to identify the lipid species that differentiate people with HIV and hepatic steatosis from those without hepatic steatosis.
The HIV Medicine Association of the Infection Diseases Society of America has released new guidance for the treatment of individuals with human immunodeficiency virus in primary care.
Patients who are immunocompromised are at a higher risk for the consequences of alcohol use disorder. In this study, researchers examined the impact of a screening tool among patients with HIV.
Influenza vaccination is important for all individuals. But it is unknown whether demographic differences in vaccination rates exist and whether the differences are affected by HIV status. In a recent...
A research team has determined the risk factors for moderate to severe hepatic steatosis among patients with HIV by comparing the prevalence rates of hepatic steatosis among patients with HIV vs without...
The International Antiviral Society-USA has released an update to its recommendations for treating and preventing HIV infection with antiretroviral drugs.
Although it is well known that patients with HIV have higher rates of incident heart failure and worse outcomes after an event, the role of NT-proBNP concentrations has not been explored. New research...
